{"id":"W2150451787","doi":"10.1111/dme.12243","title":"Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal–Bolus Type 1): 2‐year results of a randomized clinical trial","year":2013,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Management and Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novo Nordisk; Johnson and Johnson; Canadian Diabetes Association; Diabetes Canada; Eli Lilly and Company","keywords":"Insulin degludec; Insulin glargine; Medicine; Insulin aspart; Insulin; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes; Basal (medicine); Type 1 diabetes; Hypoglycemia","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007531369,0.0009907915,0.004859968,0.00134784,0.00009130503,0.00005868828,0.000571303,0.0005297977,0.0005572933],"category_scores_gemma":[0.007563781,0.0005777929,0.0003427792,0.002167629,0.001317833,0.0002566058,0.0001530481,0.00152296,0.000179519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000351915,"about_ca_system_score_gemma":0.0008530864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001232855,"about_ca_topic_score_gemma":0.0001784616,"domain_scores_codex":[0.9900283,0.001997665,0.003302436,0.001346709,0.001728771,0.001596101],"domain_scores_gemma":[0.9921302,0.003635558,0.001121849,0.001376385,0.000877046,0.0008590113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8992944,0.003963313,0.05642937,0.0003802871,0.002119956,0.0002443453,0.001056427,0.0003511044,0.0007039579,0.00002191492,0.002665712,0.03276917],"study_design_scores_gemma":[0.8968138,0.03035178,0.03849684,0.002114714,0.001461191,0.000003208234,0.0003830833,0.02806262,0.0004221545,0.0002302842,0.001003783,0.0006565219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789013,0.004032843,0.00002658519,0.005578217,0.000548763,0.00920897,0.00003408881,0.00009610838,0.001573165],"genre_scores_gemma":[0.9923364,0.002887655,0.0007818496,0.0006615305,0.0009920606,0.0006356498,0.0002402001,0.0001561683,0.001308484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03211265,"threshold_uncertainty_score":0.9996673,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02044180789382148,"score_gpt":0.2916100930684961,"score_spread":0.2711682851746746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}